Novartis: Court Case in India Begins (MSF Video)

This post was written by Nicolle Rueras.

A recent court case between the Indian Government and pharmaceutical company, Novartis, has caused a stir in the global community. Novartis is challenging Section 3(d) of India’s Patent Act, which requires companies to prove that their drug is more successful than alternative treatments for a disease to receive or extend a patent.

To get around this regulation, many companies begin “evergreening” – making minor changes to a drug that may not improve its efficacy but claim it does in order to extend its patent. If Novartis succeeds, this may open the door for other companies to follow suit, ultimately driving up prices for crucial medicines produced in India and needed around the world.

Are you interested in the APHA Trade and Health Forum?

The APHA Trade and Health Forum was formed last April.  Some of you have asked for an update as to what the forum is, what it has done, and plans for the coming year.   

This past year’s APHA conference in Washington DC included the first face-to-face business meeting of the new Forum on Trade and Health. Over 25 people from a variety of sections gathered to discuss how global trade affects public health, and what we can do about it. The Forum sponsored three oral sessions and one poster session, and co-sponsored several other events. The Forum welcomes new participants from any section! Continue reading “Are you interested in the APHA Trade and Health Forum?”